Osteoarthritic process modifies expression response to NiTi alloy presence
Jazyk angličtina Země Spojené státy americké Médium electronic
Typ dokumentu časopisecké články
Grantová podpora
15-16336S
Grantová Agentura České Republiky
PubMed
30167902
DOI
10.1007/s10856-018-6156-z
PII: 10.1007/s10856-018-6156-z
Knihovny.cz E-zdroje
- MeSH
- biokompatibilní materiály chemie farmakologie MeSH
- cytokiny MeSH
- kultivované buňky MeSH
- lidé MeSH
- lipopolysacharidy MeSH
- nikl farmakologie MeSH
- osteoartróza * MeSH
- osteoblasty účinky léků metabolismus MeSH
- regulace genové exprese účinky léků MeSH
- testování materiálů MeSH
- titan farmakologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- biokompatibilní materiály MeSH
- cytokiny MeSH
- lipopolysacharidy MeSH
- nikl MeSH
- titan MeSH
- titanium nickelide MeSH Prohlížeč
Nickel-titanium alloy (nitinol, NiTi) is a biomaterial with unique thermal shape memory, superelasticity and high damping properties. Therefore NiTi has been used in medical applications. In this in vitro study, the effect of NiTi alloy (with two surface modifications - helium and hydrogen) on gene expression profile of selected interleukins (IL-1β, IL-6 and IL-8) and matrix metalloproteinases (MMP-1 and MMP-2) in human physiological osteoblasts and human osteoarthritic osteoblasts was examined to respond to a question of the different behavior of bone tissue in the implantation of metallic materials in the presence of cells affected by the osteoarthritic process. The cells were cultivated in contact with NiTi and with or without LPS (bacterial lipolysaccharide). Changes in expression of target genes were calculated by 2-ΔΔCt method. An increased gene expression of IL-1β in osteoarthritic osteoblasts, with even higher expression in cells collected directly from the metal surface was observed. In case of physiological osteoblasts, the change in expression was detected after LPS treatment in cells surrounding the disc. Higher expression levels of IL-8 were observed in osteoarthritic osteoblasts after NiTi treatment in contact with alloy, and in physiological osteoblasts without relation to location in combination of NiTi and LPS. IL-6 was slightly increased in physiological osteoblastes after application of LPS. MMP-1 expression level was obviously significantly higher in osteoarthritic osteoblasts with differences regarding the metal surface and location. MMP-2 expression was decreased in both cell lines after LPS treatment. In conclusion, results of present study show that the NiTi alloy and the treatment by LPS, especially repeated doses of LPS, change the gene expression of selected ILs and MMPs in human osteoblast cell cultures. Some of the changes were depicted solely to osteoarthritic osteoblasts.
Zobrazit více v PubMed
Semin Arthritis Rheum. 1996 Feb;25(4):254-72 PubMed
Nat Rev Rheumatol. 2011 Jan;7(1):33-42 PubMed
Nat Clin Pract Rheumatol. 2008 Mar;4(3):128-35 PubMed
Mediators Inflamm. 1992;1(4):273-9 PubMed
J Bone Miner Metab. 2009;27(4):412-23 PubMed
Genet Mol Res. 2015 Nov 23;14(4):14811-22 PubMed
Crit Rev Oral Biol Med. 1993;4(2):197-250 PubMed
Calcif Tissue Int. 2000 Aug;67(2):151-5 PubMed
J Rheumatol. 1999 Jan;26(1):166-9 PubMed
Arthritis Rheum. 2003 Jan;48(1):134-45 PubMed
Artif Cells Blood Substit Immobil Biotechnol. 2011 Jun;39(3):137-42 PubMed
J Infect Dis. 1998 Jun;177(6):1582-7 PubMed
PLoS One. 2014 Nov 12;9(11):e90683 PubMed
Arthritis Res Ther. 2013;15(5):R111 PubMed
J Immunol. 1995 May 15;154(10):5418-25 PubMed
Biomaterials. 2002 Aug;23(16):3341-6 PubMed
Clin Exp Rheumatol. 2008 Mar-Apr;26(2):295-304 PubMed
Osteoarthritis Cartilage. 2002 Jun;10(6):491-500 PubMed
J Biomed Mater Res A. 2007 Aug;82(2):403-14 PubMed
Osteoarthritis Cartilage. 2015 Nov;23(11):1946-54 PubMed
Osteoarthritis Cartilage. 2010 Jul;18(7):942-7 PubMed
Bone. 2007 Apr;40(4):919-30 PubMed
Curr Pharm Des. 2011;17(22):2241-52 PubMed
Arthritis Rheum. 2003 Dec;48(12):3452-63 PubMed
Immunol Today. 1989 Sep;10(9):299-304 PubMed
Biomaterials. 2005 Oct;26(29):5801-7 PubMed
Bull NYU Hosp Jt Dis. 2007;65(3):222-8 PubMed
Curr Pharm Des. 2013;19(35):6375-81 PubMed
Ann Rheum Dis. 2000 Jun;59(6):455-61 PubMed
Trends Immunol. 2002 Jun;23(6):301-4 PubMed
Sci Rep. 2016 Jan 07;6:18971 PubMed
Arthritis Rheumatol. 2014 Jun;66(6):1525-36 PubMed
Crit Rev Oncol Hematol. 2002 Apr;42(1):35-56 PubMed
Blood. 1991 Apr 15;77(8):1627-52 PubMed
Biorheology. 2008;45(3-4):433-8 PubMed
Acta Biomater. 2005 Nov;1(6):705-16 PubMed
Nat Rev Rheumatol. 2010 Nov;6(11):625-35 PubMed
Invest Ophthalmol Vis Sci. 1991 Jan;32(1):88-95 PubMed
Arthritis Res Ther. 2009;11(3):224 PubMed
Curr Rheumatol Rep. 2013 May;15(5):323 PubMed
Osteoarthritis Cartilage. 2010 Apr;18(4):581-92 PubMed
Pharmacol Ther. 2014 Oct;144(1):1-11 PubMed
Osteoarthritis Cartilage. 1996 Sep;4(3):163-73 PubMed
Biomed Mater Eng. 1996;6(4):267-89 PubMed
J Biomed Mater Res. 1976 Sep;10(5):695-731 PubMed
Joint Bone Spine. 2014 Mar;81(2):137-41 PubMed
J Biomed Mater Res. 1997 Jun 15;35(4):451-7 PubMed
Biochem J. 1990 Feb 1;265(3):621-36 PubMed
J Immunol. 1990 Jan 15;144(2):499-505 PubMed
J Biomed Mater Res A. 2007 Jan;80(1):159-66 PubMed
Osteoarthritis Cartilage. 2016 Oct;24(10):1769-1775 PubMed
J Immunol. 1992 Jan 15;148(2):466-73 PubMed
J Leukoc Biol. 1994 Nov;56(5):559-64 PubMed
Anim Nutr. 2016 Jun;2(2):99-104 PubMed
Materials (Basel). 2017 Jan 10;10(1):null PubMed
J Bone Miner Metab. 2007;25(4):219-25 PubMed
Effect of Ni ion release on the cells in contact with NiTi alloys